Dementia in the elderly is a chronic syndrome with multiple causes that is already major public health burden and presents a clear therapeutic imperative to biomedical researchers. Given the time and expense of randomized clinical trials (RCTs) focused on preventing or delaying incident dementia, there is a critical public health need to validate therapies quickly and robustly to insure that the best possible candidates advance to RCTs. This application is a competitive renewal of Pharmaco- neuropathology of Brain Aging and Dementia that exploits the tremendous and unique resources of the Adult Changes in Thought Study, a large population-based longitudinal study of brain aging and incident dementia in older individuals, to identify potentially effective therapeutics for advancement to clinical trials. In this competitive renewal, we propose to determine the associations between the following mid- and late-life exposures or activities and neuropathologic, structural, and biochemical features of dementia in the elderly: "cardioprotective" doses of aspirin, hormone replacement therapy in women, two subclasses of antihypertensive drugs with proposed neuroprotective actions (calcium channel blockers and angiotensin-converting enzyme inhibitors), and level of physical exercise. These observational data will provide a unique perspective on which commonly prescribed drugs or exercise suppress specific mechanisms of disease, thereby guiding research on comparative effectiveness and aiding in the selection of regimens to pursue in RCTs.

Public Health Relevance

Dementia in the elderly is a major and growing public health burden with a clear therapeutic imperative. There are several causes of dementia that can only be definitively diagnosed by autopsy. The goal of this project is to identify potentially effective, commonly used drugs or interventions that are associated with reduced risk of the changes of these different causes of dementia in brain.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Clinical Neuroscience and Neurodegeneration Study Section (CNN)
Program Officer
Anderson, Dallas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Schools of Medicine
Salt Lake City
United States
Zip Code
Dublin, Sascha; Anderson, Melissa L; Heckbert, Susan R et al. (2014) Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci 69:609-15
Tsuang, Debby; Larson, Eric B; Li, Ge et al. (2010) Association between lifetime cigarette smoking and lewy body accumulation. Brain Pathol 20:412-8
Sonnen, J A; Larson, E B; Walker, R L et al. (2010) Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology 75:1203-10
Wang, Lucy Y; Larson, Eric B; Sonnen, Joshua A et al. (2009) Blood pressure and brain injury in older adults: findings from a community-based autopsy study. J Am Geriatr Soc 57:1975-81
Sonnen, Joshua A; Larson, Eric B; Brickell, Kiri et al. (2009) Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 66:315-22
Craft, Suzanne (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 66:300-5
Longstreth Jr, W T; Sonnen, Joshua A; Koepsell, Thomas D et al. (2009) Associations between microinfarcts and other macroscopic vascular findings on neuropathologic examination in 2 databases. Alzheimer Dis Assoc Disord 23:291-4
Woltjer, Randall L; Sonnen, Joshua A; Sokal, Izabela et al. (2009) Quantitation and mapping of cerebral detergent-insoluble proteins in the elderly. Brain Pathol 19:365-74
Sonnen, Joshua A; Larson, Eric B; Gray, Shelly L et al. (2009) Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann Neurol 65:226-9
Haneuse, Sebastien; Larson, Eric; Walker, Rod et al. (2009) Neuropathology-based risk scoring for dementia diagnosis in the elderly. J Alzheimers Dis 17:875-85

Showing the most recent 10 out of 17 publications